MENU

Fox Chase Cancer Center News

November 27, 2019

Epigenetic Therapies Could Modulate EGFR Amplification, Effecting Therapeutic Response

PHILADELPHIA (November 27, 2019) – Prolonged treatment with EGFR inhibitors can reduce the copies of EGFR, leading to therapy resistance, according to Johnathan R. Whetstine, PhD. Whetstine, the study’s corresponding author.

The 2019 Fellows induction ceremony will take place on Saturday, February 15, 2020, in Seattle during the American Association for the AAAS 2020 Annual Meeting.
November 26, 2019

Erica Golemis of Fox Chase Cancer Center Named 2019 AAAS Fellow

PHILADELPHIA (November 26, 2019) – Erica Golemis, PhD, professor, deputy chief science officer, leader of the Molecular Therapeutics Program, and The William Wikoff Smith Chair in Cancer Research at Fox Chase Cancer Center, has been named a 2019 Fellow of the American Association for the Advancement of Science.

Abbosh anticipates his research will lead to improved responses to chemotherapy, which could lead to fewer bladder cancer patients requiring a cystectomy as part of their routine care.
November 25, 2019

Abbosh Receives Grant to Better Understand Response of Bladder Cancer to Chemo

PHILADELPHIA (November 25, 2019) – Phillip Abbosh, MD, PhD, a Fox Chase Cancer Center researcher, has been awarded a $658,800 grant by the U.S. Department of Defense to investigate the role of the immune system and the presence of certain bacteria in mediated responses to chemotherapy in cancers of the bladder.

In their study, they found that in contrast to what occurs in the development of atherosclerosis, mice that were deficient in IL-27 receptor were largely protected from angiotensin II-induced AAA.
November 25, 2019

IL-27 Receptor Signaling Plays Key Role in Development of Abdominal Aortic Aneurysm

PHILADELPHIA (November 25, 2019) – In their study, researchers from Fox Chase Cancer Center found that in contrast to what occurs in the development of atherosclerosis, mice that were deficient in IL-27 receptor were largely protected from angiotensin II-induced AAA.

Survival time was calculated for 27,078 women in New Jersey diagnosed with invasive breast cancer between 2010 and 2014 and followed to December 31, 2015.
November 22, 2019

New Research Underscores Link Between Social Disparities and Breast Cancer Survival

PHILADELPHIA (November 22, 2019) – There are significant differences in breast cancer survival depending on where women live and their socioeconomic status, according to new mapping data from researchers at Fox Chase Cancer Center.

“We found that patients who were malnourished had higher rates of side effects from therapy, hospitalizations, lower response rates, and a shortened survival."
November 22, 2019

Malnutrition, Physical Inactivity Negatively Affect Cancer Care and Outcomes

PHILADELPHIA (November 22, 2019) – A number of patients involved in clinical trials for drugs being developed to treat cancer may be malnourished and sedentary, a factor that may result in inaccurate results for the trials, according to a new study from researchers at Fox Chase Cancer Center.

The doctors cover a range of specialties including, breast, surgical, gynecologic, clinical genetics, prostate, and radiation.
November 21, 2019

Eleven Fox Chase Cancer Center Physicians Named Top Docs 2019 at Main Line Today

PHILADELPHIA (November 21, 2019) – Physicians from the region were asked to vote on top doctors from an array of specialties, including breast, surgical, gynecologic, clinical genetics, prostate, and radiation oncology. 

“Gardiner’s research with pancreatic cancer is innovative and highly challenging. Her approach is creative; her perseverance and troubleshooting abilities continually prevail,” said Edna Cukierman, PhD.
November 21, 2019

Fox Chase Cancer Center’s Jaye Gardiner, PhD Selected as AAAS IF/THEN® Ambassador

PHILADELPHIA (November 21, 2019) – IF/THEN® seeks to further women in science, technology, engineering and math (STEM) by empowering current innovators and inspiring the next generation of pioneers.

Pages

Connect with Fox Chase